Indian Clindamycin Exporters: Complete Supplier Ranking with Market Share — 527 Manufacturers (2026) — TransData Nexus

Q: Who is the largest clindamycin supplier from India?

ENCUBE ETHICALS PRIVATE LIMITED is the largest clindamycin exporter from India with a 19.6% market share and export value of $17.7M.

Q: How many clindamycin suppliers are there in India?

There are 527 active clindamycin exporters in India, collectively shipping $90.2M worth of clindamycin across 7,242 shipments according to Indian Customs (DGFT) records.

Q: What is the market share of top clindamycin suppliers from India?

The top 5 clindamycin suppliers from India — ENCUBE ETHICALS PRIVATE LIMITED, AUROBINDO PHARMA LTD, MICRO LABS LIMITED, AUROBINDO PHARMA LIMITED, GLENMARK PHARMACEUTICALS LIMITED — together control 55.6% of total clindamycin export value from India.

Suresh Sormare

Clindamycin

India Pharmaceutical Trade Intelligence

$90.2M527 Suppliers144 CountriesHS 30042095

ExportsIndia → UNITED STATES60.9%India → KENYA5.1%

ImportsBELGIUM → India$14.3B FRANCE → India$32.3M

#1 Supplier: ENCUBE ETHICALS #1 Buyer: CARDINAL HEALTH

Clindamycin Suppliers from India (2026) — 527 Exporters, $90.2M Market | TransData Nexus | TransData Nexus

Who Exports Clindamycin from India — 527 Suppliers Behind a $90.2M Market

India's clindamycin export market is supplied by 527 active exporters who collectively shipped $90.2M across 7,242 shipments. ENCUBE ETHICALS PRIVATE LIMITED leads with a 19.6% market share, followed by AUROBINDO PHARMA LTD and MICRO LABS LIMITED. The top 5 suppliers together control 55.6% of total export value, reflecting a moderately competitive market structure.

Source: Indian Customs (DGFT)·Published March 2026

India's Top Clindamycin Suppliers & Exporters — 527 manufacturers, $90.2M export market, top destinations and formulations — Clindamycin supplier data — 527 exporters · $90.2M market · 7,242 shipmentsTransData Nexus · Indian Customs Data

Top Clindamycin Exporters from India — Ranked by Export Value

ENCUBE ETHICALS PRIVATE LIMITED is the leading clindamycin exporter from India, holding a 19.6% share of the $90.2M market across 7,242 shipments from 527 exporters. The top 5 suppliers — ENCUBE ETHICALS PRIVATE LIMITED, AUROBINDO PHARMA LTD, MICRO LABS LIMITED, AUROBINDO PHARMA LIMITED, GLENMARK PHARMACEUTICALS LIMITED — collectively control 55.6% of total export value, indicating a moderately concentrated market. Individual shares are: ENCUBE ETHICALS PRIVATE LIMITED (19.6%), AUROBINDO PHARMA LTD (16.1%), MICRO LABS LIMITED (7.7%), AUROBINDO PHARMA LIMITED (7.0%), GLENMARK PHARMACEUTICALS LIMITED (5.2%).

Top Clindamycin Exporters from India

Ranked by export value · 527 active suppliers · Indian Customs (DGFT) data

Mar 2026

Top Clindamycin Exporters from India — Ranked by Export Value. 527 active suppliers with export value, shipments, countries and formulations data compiled from Indian Customs records by TransData Nexus.
#	Supplier & Formulations	Value	Ships.	Ctry.	Share
1

Clindamycin — Export Intelligence Video

Visual overview of India's clindamycin supplier landscape — top suppliers, destinations, pricing, and trade routes

This video covers India's clindamycin pharmaceutical supplier landscape — $90.2M in total trade, 527 verified manufacturers. Data sourced from Indian Customs (DGFT) shipment records.

Supplier Certification & Compliance Matrix

FDA, WHO-GMP, and EU GMP status for top Clindamycin exporters

Certification and compliance status for top Clindamycin suppliers from India
Supplier	US FDA	WHO-GMP	EU GMP	ANDAs	Notes
Aurobindo Pharma Limited	Approved	Yes (September 2023)	Yes (April 2024	Not verified	Received WHO-GMP approval for Unit IV in September 2023 and EU GMP certification
Glenmark Pharmaceuticals Limited	Approved	Yes	Yes	Not verified	Holds FDA approval, WHO-GMP, and EU GMP certifications.
Micro Labs Limited	Approved	Yes	Yes	Not verified	Certified by FDA, WHO-GMP, and EU GMP.
Mylan Laboratories Limited	Approved	Yes	Yes	Not verified	Maintains FDA approval, WHO-GMP, and EU GMP certifications.
Zydus Lifesciences Limited	Approved	Yes	Yes	Not verified	Holds FDA approval, WHO-GMP, and EU GMP certifications.
The Madras Pharmaceuticals	Approved	Yes	Yes	Not verified	Certified by FDA, WHO-GMP, and EU GMP.
Medreich Limited	Approved	Yes	Yes	Not verified	Maintains FDA approval, WHO-GMP, and EU GMP certifications.
Vergo Pharma Research Laboratories Private Limited	Approved	Yes	Yes	Not verified	Holds FDA approval, WHO-GMP, and EU GMP certifications.

TransData Nexus reviewed the regulatory standing of 8 leading Clindamycin exporters from India. 8 hold US FDA facility approvals, 8 maintain WHO-GMP certification, and 8 are EU GMP compliant. For regulated markets (US, EU, Australia), prioritise suppliers with active FDA or EU GMP approvals. For semi-regulated markets (Africa, ASEAN, Latin America), WHO-GMP certification is the minimum recommended standard.

Certification status compiled from publicly available regulatory databases including FDA Orange Book, WHO Prequalification database, and EMA GMP registry. Buyers should independently verify compliance status with the relevant regulatory authority before placing orders.

TransData Nexus Research · Mar 2026

Manufacturing Hub Analysis — Vendor Proximity

India's pharmaceutical clusters relevant to Clindamycin sourcing

1Hyderabad — Bulk Drug Capital

Hyderabad, often referred to as the "Bulk Drug Capital of India," contributes over 40% to the nation's bulk drug production. This prominence is supported by the presence of major pharmaceutical companies such as Aurobindo Pharma Ltd., which has reported Clindamycin exports totaling $14.6 million, accounting for 16.1% of the market share. The city's robust infrastructure and skilled workforce make it a pivotal hub for active pharmaceutical ingredient (API) manufacturing.

2Ahmedabad-Vadodara — Formulations Hub

The Ahmedabad-Vadodara corridor in Gujarat is renowned for its focus on pharmaceutical formulations. Vadodara, in particular, hosts Alembic Pharmaceuticals, a company with a significant presence in the production of various formulations. The region's emphasis on finished dosage forms complements the bulk drug production capabilities of other clusters, contributing to a comprehensive pharmaceutical manufacturing ecosystem.

3Mumbai-Thane-Raigad — Export Gateway

The Mumbai-Thane-Raigad belt serves as a critical export gateway for pharmaceutical products. Companies like Glenmark Pharmaceuticals Limited, headquartered in Mumbai, have reported Clindamycin exports amounting to $4.7 million, representing 5.2% of the market share. The region's well-established port facilities and logistical advantages facilitate efficient international distribution, reinforcing its role in global pharmaceutical trade.

Recent M&A, Collaborations & Capacity Expansions

Industry developments among top Clindamycin exporters from India

July 2024

M&A

Glenmark Pharmaceuticals Limited — Glenmark divests 75% stake in Glenmark Life Sciences

In July 2024, Glenmark Pharmaceuticals Limited completed the divestment of a 75% stake in its subsidiary, Glenmark Life Sciences, to Nirma Limited for approximately ₹5,651 crore. This strategic move aimed to reduce debt and refocus on Glenmark's core innovative pipeline. - IMPACT: This divestment may lead to a reallocation of resources within Glenmark, potentially affecting its Clindamycin production and export strategies.

Impact: This divestment may lead to a reallocation of resources within Glenmark, potentially affecting its Clindamycin production and export strategies.

May 2024

Collaboration

Aurobindo Pharma Limited — Aurobindo's TheraNym Biologics partners with Merck for biologics manufacturing

In May 2024, TheraNym Biologics, a wholly owned subsidiary of Aurobindo Pharma Limited, signed an agreement with Merck & Co. to expand its biologics manufacturing facilities and explore contract manufacturing operations for biologics. - IMPACT: While this collaboration focuses on biologics, it may influence Aurobindo's overall manufacturing capacity and resource allocation, potentially impacting Clindamycin production and exports.

Impact: While this collaboration focuses on biologics, it may influence Aurobindo's overall manufacturing capacity and resource allocation, potentially impacting Clindamycin production and exports.

Common Questions — Clindamycin Suppliers from India

Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus

Q Which clindamycin supplier from India is the most reliable for bulk orders?

Based on shipment frequency and export consistency, ENCUBE ETHICALS PRIVATE LIMITED leads with 291 recorded shipments worth $17.7M. AUROBINDO PHARMA LTD (188 shipments) and MICRO LABS LIMITED (93 shipments) are also established high-volume exporters.

Q How many clindamycin manufacturers are there in India?

India has 527 active clindamycin exporters with a combined export market of $90.2M across 7,242 shipments to 144 countries. The top 5 suppliers hold 55.6% of total export value.

Q What certifications should I verify?

Verify: WHO-GMP certification (most markets), US FDA approval (United States), EU GMP certificate (EU/EEA), and Free Sale Certificate from CDSCO. Always request a Certificate of Analysis (CoA) and Certificate of Origin (CoO).

Q What is the typical price range for clindamycin from India?

Average FOB unit price: $4.78 per unit, ranging from $0.01 to $1003.67. Average shipment value: $12.5K.

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Clindamycin

Clindamycin

Who Exports Clindamycin from India — 527 Suppliers Behind a $90.2M Market

Top Clindamycin Exporters from India — Ranked by Export Value

Top Clindamycin Exporters from India

Related Analysis

Need Details?

Clindamycin — Export Intelligence Video

Supplier Certification & Compliance Matrix

Manufacturing Hub Analysis — Vendor Proximity

1Hyderabad — Bulk Drug Capital

2Ahmedabad-Vadodara — Formulations Hub

3Mumbai-Thane-Raigad — Export Gateway

Recent M&A, Collaborations & Capacity Expansions

Glenmark Pharmaceuticals Limited — Glenmark divests 75% stake in Glenmark Life Sciences

Aurobindo Pharma Limited — Aurobindo's TheraNym Biologics partners with Merck for biologics manufacturing

Common Questions — Clindamycin Suppliers from India

Q Which clindamycin supplier from India is the most reliable for bulk orders?

Q How many clindamycin manufacturers are there in India?

Q What certifications should I verify?

Q What is the typical price range for clindamycin from India?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

4Baddi-Nalagarh — Tax Incentive Zone

5Sourcing Recommendations

Glenmark Pharmaceuticals Limited — Glenmark transfers consumer care business to new subsidiary

Analysis Methodology